VCYT Form 4: John Leite withholds 2,902 RSU shares to cover taxes

Rhea-AI Filing Summary

John Leite, Chief Commercial Officer-CLIA of Veracyte, Inc. (VCYT), reported a transaction dated 09/02/2025 in which 2,902 shares of the company's common stock were withheld at a price of $30.11 to satisfy tax withholding obligations related to the vesting of restricted stock units. The filing clarifies that the withheld shares do not represent a sale. After the withholding, the reporting person beneficially owned 91,638 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jonathan Wygant, on 09/04/2025. The form indicates the filing was made by one reporting person and identifies the reporting persons address as South San Francisco, CA.

Insights

Corporate Governance Expert

TL;DR: Routine tax-withholding on RSU vesting; no sale or change in economic exposure reported.

The Form 4 documents a common administrative action where 2,902 vested RSU shares were withheld to cover taxes. This is a non-dispositive transfer that does not change the reporting person's stated direct ownership of 91,638 shares. From a governance perspective, such withholdings are customary and do not signal insider selling or liquidity events. The filing is complete and includes an attorney-in-fact signature, which is acceptable practice.

Securities Analyst

TL;DR: Transaction is non-material to company valuation; it reflects routine compensation settlement.

Withholding 2,902 shares at $30.11 to satisfy tax obligations on RSU vesting is a standard compensation-related action and explicitly noted as not a sale. The post-transaction direct beneficial ownership of 91,638 shares should be monitored only if future filings show sales or additional disposals. There is no indication of market-impacting insider liquidity from this single administrative transaction.

Insider Trade Summary

Net Seller: 2,902 shares

Net Sell 1 txn

Insider Leite John

Role Chief Commercial Officer-CLIA

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	2,902	$30.11	$87K

Holdings After Transaction: Common Stock — 91,638 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 09/04/2025 - 05:11 PM Learn about SEC filing dates

FAQ

What did Veracyte (VCYT) insider John Leite report on Form 4?

The Form 4 reports that 2,902 common shares were withheld at $30.11 to satisfy tax withholding on vested restricted stock units; this was not a sale.

How many Veracyte shares does John Leite beneficially own after the transaction?

After the withholding, the reporting person beneficially owned 91,638 shares of Veracyte common stock.

When did the transaction and the Form 4 signature occur?

The transaction date is 09/02/2025 and the Form 4 was signed by an attorney-in-fact on 09/04/2025.

Was the withheld share action recorded as a sale on Form 4?

No. The filing explicitly states the withheld shares were to satisfy tax withholding on RSU vesting and do not represent a sale.

What is John Leites role at Veracyte listed on the Form 4?

He is listed as Chief Commercial Officer-CLIA and the form indicates he is an officer of the issuer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leite John

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer-CLIA

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		F(1)		2,902	D	$30.11	91,638	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.